Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 24,237 shares at $54.27 ($1.3M) on 2026-06-26, disclosed to the SEC on 2026-06-26.
Scheduled sale ($1.3M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.22 | 207 | $11K | 0.8% |
| 2 | $54.27 | 6,683 | $363K | 27.1% |
| 3 | $54.34 | 312 | $17K | 1.3% |
| 4 | $55.23 | 356 | $20K | 1.5% |
| 5 | $55.27 | 9,137 | $505K | 37.7% |
| 6 | $55.30 | 602 |
| $33K |
| 2.5% |
| 7 | $55.99 | 332 | $19K | 1.4% |
| 8 | $56.12 | 6,417 | $360K | 26.9% |
| 9 | $56.27 | 191 | $11K | 0.8% |
| Total | $55.22 avg | 24,237 | $1.3M | 100% |
| Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |
| PCVX | SELL | 2024-11-08 | $246K | — | Filing → |